Lithium chloride prevents brain damage linked to foetal alcohol syndrome
A single dose of lithium chloride can block sleep disturbances, memory loss, and learning problems tied to foetal alcohol syndrome...
List view / Grid view
News
Shorter treatment course better for intermediate risk prostate cancer?
New research suggests that treatment with a shorter course of radiation using higher doses over fewer days may be the preferred approach for some men with intermediate-risk prostate cancer.
Synthetic-biological hybrid nanocapsule combats diseased cells
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases...
Ogivri approved as the first biosimilar against certain breast and stomach cancers
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
Neoantigen-based immunotherapy targets misshapen protein in DIPG
Children with an extremely deadly form of brain cancer may benefit from a new treatment that aims to direct an immune response against an abnormally shaped protein found on cancer cells...
3-D-printed prosthetic implants could improve treatment for hearing loss
Using CT scans and 3-D printing researchers have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear...
Scientists identify bacterial link with oesophageal cancer
Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may directly affect their risk of developing oesophageal cancer.
Scientists find genetic link between immune system and lymphoma
People who inherit genetic changes that alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, according to new study by Institute of Cancer Research.
EMA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated NSCLC
The EMA has accepted a variation to the MAAv for Tagrisso, for the 1st-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer...
Simple blood test may predict MRI disease activity in MS
A blood test to monitor a nerve protein in the blood of people with multiple sclerosis may help predict whether disease activity is flaring up...
PAC-1-temozolomide combination shows promise for anaplastic astrocytoma
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma...
Report highlights pharma’s key role in Scotland’s economy
Following new Fraser of Allander Institute analysis, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research, development and manufacturing capabilities...
GPS-enabled nanoparticles seek and destroy cancer stem cells
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
Lung function of COPD patients improved with Ultibro Breezhaler
Novartis has announced positive results from the FLASH study examining the safety and efficacy of directly switching COPD patients from Seretide to Ultibro Breezhaler...
Pembrolizumab shows hope for cancerous gestational trophoblastic disease
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
